Literature DB >> 8640775

Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss.

R Maestro1, S Piccinin, C Doglioni, D Gasparotto, T Vukosavljevic, S Sulfaro, L Barzan, M Boiocchi.   

Abstract

Heal and neck squamous cell carcinomas show frequent cytogenetic alterations involving the long arm of chromosome 13. To define the extent of 13q deletions and to identify the minimal areas of chromosome loss, 48 primary squamous cell carcinomas of the head and neck were analyzed for loss of heterozygosity using 11 different polymorphic loci. About 67% of the tumors displayed loss of genetic material at 13q. Most of the cases showed loss of the entire long arm of the chromosome. However, the presence of partial deletions in 10 cases provided evidence of the existence of two preferential sites of chromosome loss at 13q32-ter and 13q14.2-q14.3. The colocalization of the 13q14 minimal region of deletion with the retinoblastoma (RB) gene, which has been proposed as an oncosuppressor in diverse tumor types, prompted us to verify the involvement of this gene in the development of head and neck cancer. No significant variation in RB protein or RB mRNA expression was detected, thus excluding a role for such a gene in the genesis of this type of tumor. Taken together, our data suggest the existence of two new tumor suppressor genes (one close to and one distal to RB), which play a role in the development and/or progression of head and neck squamous cell carcinomas.

Entities:  

Mesh:

Year:  1996        PMID: 8640775

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour.

Authors:  Md Golam Sabbir; Anup Roy; Syamsundar Mandal; Aniruddha Dam; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

Review 2.  Polycomb group proteins: navigators of lineage pathways led astray in cancer.

Authors:  Adrian P Bracken; Kristian Helin
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

3.  DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.

Authors:  M Nagashima; M Shiseki; K Miura; K Hagiwara; S P Linke; R Pedeux; X W Wang; J Yokota; K Riabowol; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 4.  DNA copy number losses in human neoplasms.

Authors:  S Knuutila; Y Aalto; K Autio; A M Björkqvist; W El-Rifai; S Hemmer; T Huhta; E Kettunen; S Kiuru-Kuhlefelt; M L Larramendy; T Lushnikova; O Monni; H Pere; J Tapper; M Tarkkanen; A Varis; V M Wasenius; M Wolf; Y Zhu
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

5.  The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD.

Authors:  Mikael Lerner; Martin Corcoran; Diana Cepeda; Michael L Nielsen; Roman Zubarev; Fredrik Pontén; Mathias Uhlén; Sophia Hober; Dan Grandér; Olle Sangfelt
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

6.  Genomic changes in glioblastoma cell lines detected by comparative genomic hybridization.

Authors:  V S Venkatraj; M Begemann; A Sobrino; J N Bruce; I B Weinstein; D Warburton
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

7.  Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.

Authors:  Wei Gong; Michael Russell; Keiko Suzuki; Karl Riabowol
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Microsatellite instability in squamous cell carcinomas of the head and neck related to field cancerization phenomena.

Authors:  S Piccinin; D Gasparotto; T Vukosavljevic; L Barzan; S Sulfaro; R Maestro; M Boiocchi
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

9.  The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer.

Authors:  M Partridge; G Emilion; S Pateromichelakis; R A'Hern; G Lee; E Phillips; J Langdon
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

10.  The expression of retinoblastoma tumor suppressor protein in oral cancers and precancers: A clinicopathological study.

Authors:  Sunila Thomas; Anita Balan; Prabha Balaram
Journal:  Dent Res J (Isfahan)       Date:  2015 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.